Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

July 24, 2021

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Psoriasis
Interventions
DRUG

Risankizumab

Subcutaneous (SC) injection.

Trial Locations (41)

24105

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 243883, Kiel

26506

West Virginia University Hospitals /ID# 263438, Morgantown

28007

Hospital General Universitario Gregorio Maranon /ID# 241099, Madrid

28031

Hospital Universitario Infanta Leonor /ID# 241100, Madrid

28041

Hospital Universitario 12 de Octubre /ID# 241102, Madrid

29425

Medical University of South Carolina /ID# 248831, Charleston

32256

Solutions Through Adv Rch /ID# 226104, Jacksonville

33607

Advanced Clinical Research Institute /ID# 248827, Tampa

35233

UAB Department of Dermatology /ID# 252305, Birmingham

36071

Complejo Hospitalario Universitario de Pontevedra /ID# 241101, Pontevedra

44106

Univ Hosp Cleveland /ID# 248825, Cleveland

44124

Apex Clinical Research Center /ID# 248830, Mayfield Heights

48149

Universitaetsklinikum Muenster /ID# 243905, Münster

48455

Fachklinik Bad Bentheim /ID# 243904, Bad Bentheim

53127

Universitaetsklinikum Bonn /ID# 243910, Bonn

53226

Wisconsin Medical Center /ID# 263437, Milwaukee

55131

Universitaetsmedizin Mainz /ID# 243907, Mainz

60008

Arlington Dermatology /ID# 226097, Rolling Meadows

60561

University Dermatology and Vein Clinic, LLC /ID# 226100, Darien

89509

Skin Cancer and Dermatology Institute - Reno /ID# 248828, Reno

92123

University of California San Diego - Rady Children's Hospital San Diego /ID# 252348, San Diego

92708

First OC Dermatology /ID# 226942, Fountain Valley

95815

Integrative Skin Science and Research /ID# 226108, Sacramento

33709-1405

Olympian Clinical Research- St. Petersburg /ID# 226106, St. Petersburg

A1A 4Y3

Karma Clinical Trials /ID# 233985, St. John's

M5G 1X8

Hospital for Sick Children /ID# 233986, Toronto

01307

Universitaetsklinikum Carl Gustav Carus Dresden /ID# 243908, Dresden

467-8602

Nagoya City University Hospital /ID# 248429, Nagoya

514-8507

Mie University Hospital /ID# 263008, Tsu

573-1191

Kansai Medical University Hirakata Hospital /ID# 252332, Hirakata-shi

160-0023

Tokyo Medical University Hospital /ID# 252331, Shinjuku-ku

01-817

High-Med Przychodnia Specjalistyczna /ID# 243846, Warsaw

35-055

Uniwersytecki Szpital Kliniczny im. F. Chopina w Rzeszowie /ID# 243850, Rzeszów

80-546

Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 243849, Gdansk

90-265

Dermed Centrum Medyczne Sp. z o.o /ID# 243847, Lodz

90-436

Dermoklinika Medical Center /ID# 243848, Lodz

08950

Hospital Sant Joan de Deu /ID# 241103, Esplugues de Llobregat

EX2 5DW

Royal Devon & Exeter Hospital /ID# 245101, Exeter

PL6 8DH

Derriford Hospital and the Royal Eye Infirmary /ID# 245104, Plymouth

SE1 9RT

Dup_Guys and St Thomas NHS Foundation Trust - Guy's Hospital /ID# 245100, London

SW10 9NH

Chelsea and Westminster Hospital /ID# 245102, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY